Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:INNO)

Innocan Pharma Reports Third Quarter 2024 Financial Results

Canada NewsWire 3 days ago

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity

Research 9 days ago

Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand

Canada NewsWire 12 days ago

Innocan Pharma to Present at the 2024 ThinkEquity Conference

GlobeNewswire October 21, 2024

Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience

Canada NewsWire October 16, 2024

Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs

Canada NewsWire October 11, 2024

An investor's opportunity in injectable liposomal CBD's potential

Research October 10, 2024

Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide

Canada NewsWire October 9, 2024

Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting

Canada NewsWire September 3, 2024
View More News ››

Opinion & Analysis (CSE:INNO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:INNO)

INNO Surges +10% While Cannabis Sector Rallies

InnoCan Pharma is riding sector-wide momentum, posting a solid +10% gain on the day. If news of a new drug hits, it could ignite even...
EquityScout411 - 2 days ago

positive FDA engagement

I like this company, I think there can be multiple revenue streams from the LPT-CBD
stocksavvy2000 - 5 days ago

good potential but IF results show safety and effective

it will take years before approval
edrose - October 14, 2024

Excellente opportunité pour investisseur

Derniere nouvelle: https://www.medicaldaily.com/professor-chezy-barenholz-cbd-powered-revolution-pharmaceuticals-466088
realistic25 - October 12, 2024

An investor's opportunity in injectable liposomal CBD's pote

LOOK : https://stockhouse.com/news/newswire/2024/10/10/an-investor-s-opportunity-injectable-liposomal-cbd-s-potential
realistic25 - October 12, 2024

Advances Liposomal CBD with Positive Response from FDA

HERZLIYA, Israel and CALGARY, Alberta, Sept. 3, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) ...
Betteryear2 - September 3, 2024
View more Bullboard ››

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc. is a Canada-based company, which is focused exploration and development property bank which ...
View More »